HIGHLIGHTS
- who: Joanna Sophia J. Vinke and colleagues from the Northeast Agricultural University, China have published the article: Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial, in the Journal: (JOURNAL)
- what: The authors aimed to address the hypothesis that in iron-deficient KTRs, ferric carboxymaltose (FCM) improves the humoral and cellular response after vaccination against SARS-CoV-2. Patient population and study design COVAC-EFFECT is a secondary analysis performed in a subpop ulation of the ongoing EFFECT-K Tx study (NCT03769441 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.